▲ +55.50% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for CloudMD Software & Services in the last 3 months. The average price target is C$3.25, with a high forecast of C$4.00 and a low forecast of C$2.50. The average price target represents a 55.50% upside from the last price of C$2.09.
The current consensus among 2 polled investment analysts is to buy stock in CloudMD Software & Services. This rating has held steady since January 2021, when it changed from a Hold consensus rating.
CloudMD Software & Services Inc., a technology company, provides SaaS based health technology solutions to medical clinics in Canada. The company provides digital technologies that connect doctors and allied health care providers to their patients. It also engages in retailing of prescription drugs, over-the-counter drugs, and other front store items through primary care clinics and pharmacies, as well as provide clinical, medical reviews, and compounding services. The company was formerly known as Premier Health Group Inc. and changed its name to CloudMD Software & Services Inc. in February 2020. CloudMD Software & Services Inc. was incorporated in 2013 and is headquartered in Victoria, Canada.